Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
Life Sciences Times
-
April 5, 2022
0
Venture Capital
Venatorx Pharmaceuticals Raises Series C Financing Led by the AMR Action Fund
Life Sciences Times
-
April 4, 2022
0
Venture Capital
Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund
Life Sciences Times
-
April 4, 2022
0
Venture Capital
Mednow Closes Previously Announced Acquisition of Pharmacy in Toronto
Life Sciences Times
-
April 1, 2022
0
Venture Capital
VideaHealth Raises $20 Million to Expand AI in the Dentist’s Chair for Millions of Patients
Life Sciences Times
-
March 31, 2022
0
Venture Capital
Thomas H. Lee Partners Acquires Intelligent Medical Objects
Life Sciences Times
-
March 31, 2022
0
Venture Capital
Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform
Life Sciences Times
-
March 30, 2022
0
Venture Capital
NAMSA to Acquire European-Based Medanex Clinic to Expand Early-Stage Preclinical Research Capabilities
Life Sciences Times
-
March 30, 2022
0
Venture Capital
Linus Health Announces Acquisition of Kinesis Health Technologies
Life Sciences Times
-
March 30, 2022
0
Venture Capital
VivoSense Announces Closing of $25M Series A Financing
Life Sciences Times
-
March 30, 2022
0
Venture Capital
Scientist.com Expands Science as a Service® Platform with Acquisition of Notch8
Life Sciences Times
-
March 29, 2022
0
Venture Capital
Appili Therapeutics Announces Non-Convertible Secured Loan of US$3.6 Million and License and Distribution Agreement with Long Zone Holdings
Life Sciences Times
-
March 29, 2022
0
1
...
80
81
82
...
115
Page 81 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026